- Syqe Medical, Ltd. and TerrAscend Corp. announced an exclusive distribution agreement to bring Syqe’s flagship product, the SyqeTM Inhaler, to the Canadian market. - TerrAscend will utilize their platform to both provide high-quality guidance to patients on use of the Syqe device and educate the medical community on the benefits of medical cannabis and the Syqe treatment. - For the first time ever, the amount of THC in the bloodstream can be accurately controlled in a consistent,
Read More
Connected Metered Dose Inhaler
Syqe Medical Releases Pharmaceutical-Grade Medical Marijuana Inhaler
Syqe Medical, an Israeli pharma-tech company, recently launched its newest administering device for cannabis in the form of a non-combustion inhaler. The Syqe Inhaler™ is the company’s flagship product that utilizes innovative technology to administer proper doses of cannabis for medical marijuana patients in Israel. Syqe’s breakthrough drug delivery technology introduces complex respiration technique automation, electronic selective dosing, remote clinical monitoring and dose
Read More
Cleveland Clinic Study: Propeller Health’s Smart Inhalers Reduces Hospitalizations, ER Visits for COPD Patients
Cleveland Clinic today released research that uses Propeller Health’s smart inhaler platform to show that digital medicines significantly reduced hospital visits for COPD patients. COPD is a term applied to a family of diseases that includes emphysema, chronic bronchitis, and emphysema due to alpha-1 antitrypsin deficiency. The research findings published in The Journal of Telemedicine and Telecare marks the first-ever research to assess the impact of a digital medicine on healthcare utilization
Read More
Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly
The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
Cohero Health, Presspart Group Announces Commercialization of Connected Metered Dose Inhaler
Cohero Health, an NYC-based digital health company focused on developing connected health tools and technologies to improve respiratory care and Presspart Group, a specialist medical device and pharmaceutical component manufacturer, has announced the completion of their connected metered dose inhaler (eMDI). eMDI is the result of a multi-year development effort between Cohero Health and Presspart. The relationship has resulted in production of functional devices, now readily available to the
Read More
